Raltegravir

Isentress - API Insight, 2019 - ResearchAndMarkets.com

Retrieved on: 
Friday, May 31, 2019
Health, Pharmaceutical, Chemical compounds, Integrase inhibitors, Merck, Organic compounds, Oxadiazoles, RTT, Raltegravir, Application programming interface, Web API, Chemistry

The "Isentress - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Isentress - API Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • Isentress - API Insight, 2019 provides product and API manufacturers' details across the globe along with the location.
  • The report gives the clear idea on the country wise DMF filed by worldwide companies related to Isentress.
  • The report also highlights the patent details of Isentress.

Isentress - Drug Insight, 2019 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 1, 2019
Health, AIDS, Infectious diseases, Pharmaceutical, Integrase inhibitors, Business intelligence, Strategic management, Merck, Oxadiazoles, Raltegravir, SWOT analysis, Chemistry, Organic chemistry

The "Isentress - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Isentress - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
  • Isentress Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.
  • The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country.
  • In addition to this, the report also provides the SWOT analysis for Isentress and emerging therapies in this space.